Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

TSXV:VPT - Post Discussion

VentriPoint Diagnostics Ltd > Us2.ai has a feature that leverages the speed of our AI,
View:
Post by jopatclo on Nov 11, 2024 2:27pm

Us2.ai has a feature that leverages the speed of our AI,

Interesting see *like this Gary Dunn View Gary Dunn’s profile Out of network
Assistant Director, Imaging at Duke Clinical Research Institute
&
*Like this Hannah Crane View Hannah Crane’s profile Out of network
Clinical Applications Specialist & Cardiac Sonographer ( Ventripoint ) on post 
Was chatting with some hashtagecho enthusiasts recently and realized I should share a very useful and powerful application of hashtagAI in hashtagechocardiography: longitudinal comparison of multiple echos of a single patient can offer significant clinical benefit but is often too time consuming to be practical. Us2.ai has a feature that leverages the speed of our AI, analyzing multiple patient echos in ~2-mins, then graphing each parameter longitudinally and presenting the annotations side by side (including GLS), removing operator variability and bias in the process (our AI is 100% reproducible).

Imagine analyzing 3-4 echos of a patient in just a few minutes with zero human intervention and zero clicks required :-)
Comment by jopatclo on Nov 11, 2024 3:34pm
Interesting click https://ascendcv.com/product-and-services/gen3echo/#  Integrations Just click on "Integrations".see  Seamless, flexible integration with heterogeneous AI, imaging and enterprise IT environments enables a best-of breed approach. Examples include: Us2.ai - Benefit from the the industry’s most sophisticated integration of Us2.ai.  ...more  
Comment by jopatclo on Nov 11, 2024 3:50pm
Daniel I.Daniel I. • 3rd+ • 3rd+Commercial Director | Driving Sales Growth, Diagnostic ImagingCommercial Director | Driving Sales Growth, Diagnostic Imaging10h • Edited • 10 hours ago Follow   Proud to announce that Queen Elizabeth Hospital (QEH) in Hong Kong has become the first public hospital in the region to integrate Us2.ai's AI ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities